相关实验视频

Updated: May 1, 2026

A Mouse Model of in Utero Transplantation

A Mouse Model of in Utero Transplantation

Published on: January 27, 2011

在子宫治疗脊柱肌肉缩:更接近临床翻译

Eduardo F Tizzano^1,2, Georg Lindner¹, Ellie Chilcott³

¹Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain.

Brain : a journal of neurology

|April 7, 2025

概括

脊椎肌肉缩 (SMA) 治疗正在进步,基因疗法和其他方法显示出有前途. 在子宫内治疗正在探索,以潜在地预防出生前严重的SMA表现.

科学领域:

神经学神经学
遗传学是一个遗传学.
发展生物学发展生物学

背景情况:

脊椎肌肉缩 (SMA) 是一种影响运动神经元的遗传疾病,影响肌肉功能.
目前的治疗方法针对SMN1基因或SMN2基因调制,目前已批准了三种治疗方法.
严重的SMA (I型) 开始于产前,使得产后治疗可能不足.

研究的目的:

审查SMA的临床和发育方面.
讨论已批准的SMA先进疗法.
探索子宫内SMA治疗的理由,选择和挑战.

主要方法:

对 SMA 的临床和遗传方面的文献综述.
对已批准的SMA疗法 (基因疗法,ASO,小分子) 的分析.
讨论产前干预策略,包括伦理和安全方面的考虑.

主要成果:

SMA是一种全身性疾病,具有产前起源,特别是在I型中.
经批准的疗法提供疾病修饰,但如果在产后开始,可能会受到限制.
在子宫内治疗提供了一个机会,可以更早地干预疾病的进展.

结论:

通过子宫内治疗进行产前干预可以减轻或预防SMA的表现.
经过精心设计的临床试验,在子宫内治疗SMA需要进行翻译.
为了成功实施产前治疗,必须解决伦理和安全问题.

关键词:

在子宫内进行治疗.胎儿的胎儿是一个胎儿.基因治疗的基因疗法人类发展人类发展在症状前的症状.脊柱肌肉缩脊柱肌肉缩脊柱肌肉缩

更多相关视频

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Published on: October 9, 2018

相关概念视频

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...